“Psoriasis Patients on Chronic Biologic Therapy May Benefit from Additional Treatment-Study Design and Baseline Characteristics”, J of Skin, vol. 2, no. S1, p. S12, Feb. 2018, doi: 10.25251/skin.2.supp.13.